Skip to search.
 BSE Down 2.23% NSE Down 2.33%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
8.57 Down 0.14(1.61%) 1:30am
|After Hours : 8.57 0.00 (0.00%) 2:40am
Add to Portfolio
Prev Close:8.71
Open:8.52
Bid:8.55 x 500
Ask:8.84 x 4000
1y Target Est:15.50
Beta:0.220443
Next Earnings Date:N/A
Day's Range:8.42 - 9.03
52wk Range:2.31 - 14.40
Volume:2,690,929
Avg Vol (3m):3,689,400
Market Cap:1.12B
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ZIOP at this time.

Comparison

Symbol% ChgMkt Cap
ZIOPDown 1.61%1.12B
IMGNDown 3.57%1.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):744.67
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.51
Quarterly EPS Est (Sep-15) :-0.13
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback